Literature DB >> 21603891

Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.

James P Zacny1, Sandra Gutierrez.   

Abstract

RATIONALE: Nonmedical use of prescription opioids is sometimes accompanied by the ingestion of ethanol. Whether ethanol increases the abuse liability-related effects of prescription opioids has not been determined.
OBJECTIVE: The purpose of this study was to characterize the subjective, psychomotor, and physiological effects of oxycodone, a widely prescribed and abused opioid, and ethanol, alone and in combination.
METHODS: Fourteen volunteers participated in a randomized, crossover trial in which they were exposed to placebo, oxycodone (10 mg), two doses of ethanol (0.3 and 0.6 g/kg), and oxycodone combined with the lower dose and the higher dose of ethanol on separate sessions.
RESULTS: Several abuse liability-related subjective effects (drug liking, take again, pleasant bodily sensations) were not increased by the low dose of ethanol or oxycodone alone relative to placebo, but were when the two were combined. Self-reported liking of the higher dose of ethanol was higher than that of placebo, but oxycodone neither increased nor decreased this effect. Psychomotor and cognitive performance was not affected by any of the active drug conditions. Absorption of ethanol was decreased by oxycodone.
CONCLUSIONS: In this study, 10 mg of oral oxycodone combined with a low dose of ethanol generated abuse liability-related effects, but when tested separately, they did not. Further psychopharmacological investigations of this combination are warranted in light of these findings and the fact that nonmedical use of prescription opioids is sometimes accompanied by use of ethanol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21603891     DOI: 10.1007/s00213-011-2349-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety.

Authors:  Todd C Helmus; Manuel Tancer; Chris-Ellyn Johanson
Journal:  Exp Clin Psychopharmacol       Date:  2005-11       Impact factor: 3.157

2.  Reinforcing effects of a combination of ethanol and methadone relative to each drug alone.

Authors:  K L Shelton; M J Macenski; R A Meisch
Journal:  Pharmacol Biochem Behav       Date:  1998-12       Impact factor: 3.533

3.  Nonmedical prescription analgesic use and concurrent alcohol consumption among college students.

Authors:  Laura M Garnier; Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Kevin E O'Grady; Eric D Wish
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Biphasic stimulant and sedative effects of ethanol: are children of alcoholics really different?

Authors:  Joel Erblich; Mitchell Earleywine; Bryna Erblich; Dana H Bovbjerg
Journal:  Addict Behav       Date:  2003-08       Impact factor: 3.913

5.  Individual differences in the biphasic effects of ethanol.

Authors:  L Holdstock; H de Wit
Journal:  Alcohol Clin Exp Res       Date:  1998-12       Impact factor: 3.455

6.  Assessment of the relative reinforcement value of smoking and drinking using a multiple-choice measurement strategy.

Authors:  Joy A Schmitz; Shelly L Sayre; Patricia S Hokanson; Ralph Spiga
Journal:  Nicotine Tob Res       Date:  2003-10       Impact factor: 4.244

7.  Effect of meptazinol and ethanol on human psychomotor performance and mood ratings.

Authors:  G Tedeschi; A T Smith; A Richens
Journal:  Hum Toxicol       Date:  1984-02

8.  Comparison of the effects of therapeutic doses of meptazinol and a dextropropoxyphene/paracetamol mixture alone and in combination with ethanol on ventilatory function and saccadic eye movements.

Authors:  N A Ali; R W Marshall; E M Allen; D F Graham; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

9.  The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.

Authors:  Sharon L Walsh; Paul A Nuzzo; Michelle R Lofwall; Joseph R Holtman
Journal:  Drug Alcohol Depend       Date:  2008-07-07       Impact factor: 4.492

10.  Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.

Authors:  C Girre; M Hirschhorn; L Bertaux; S Palombo; F Dellatolas; R Ngo; M Moreno; P E Fournier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more
  14 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

2.  High-intensity drinking and nonmedical use of prescription drugs: Results from a national survey of 12th grade students.

Authors:  Sean Esteban McCabe; Philip Veliz; Megan E Patrick
Journal:  Drug Alcohol Depend       Date:  2017-06-29       Impact factor: 4.492

3.  Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

4.  Co-ingestion of prescription opioids and other drugs among high school seniors: results from a national study.

Authors:  Sean Esteban McCabe; Brady T West; Christian J Teter; Carol J Boyd
Journal:  Drug Alcohol Depend       Date:  2012-05-18       Impact factor: 4.492

5.  Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Pharmacol Biochem Behav       Date:  2011-11-04       Impact factor: 3.533

6.  A Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors.

Authors:  Manoj Kumar; Manish Kumar; John M Freund; Glenn H Dillon
Journal:  J Pharmacol Exp Ther       Date:  2017-06-22       Impact factor: 4.030

7.  Elevated customary alcohol consumption attenuates opioid effects.

Authors:  Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman
Journal:  Pharmacol Biochem Behav       Date:  2021-11-04       Impact factor: 3.533

Review 8.  Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Authors:  Jeffrey A Gudin; Shanthi Mogali; Jermaine D Jones; Sandra D Comer
Journal:  Postgrad Med       Date:  2013-07       Impact factor: 3.840

9.  Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adults.

Authors:  Shanna Babalonis; Marion A Coe; Paul A Nuzzo; Michelle R Lofwall; Nur Ali; Paul A Sloan; Laura C Fanucchi; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2020-11-09       Impact factor: 4.530

10.  The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids.

Authors:  Stephen Bruehl; John W Burns; Amanda Morgan; Kelli Koltyn; Rajnish Gupta; Asokumar Buvanendran; David Edwards; Melissa Chont; Philip J Kingsley; Larry Marnett; Amanda Stone; Sachin Patel
Journal:  Pain       Date:  2019-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.